Frontlight ResearchEarly access
Trial site
Instituto de Cardiologia do Rio Grande do Sul
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Stroke3 trials
- Coronary artery disease2 trials
- High blood pressure2 trials
- Amyloidosis1 trial
- Chronic kidney disease1 trial
- Obesity1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 33 trials
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Instituto de Cardiologia do Rio Grande do Sul3 trials
- Amgen1 trial
- Eidos Therapeutics, a BridgeBio company1 trial
- Eli Lilly and Company1 trial
- Population Health Research Institute1 trial
Running trials
Recruiting
Not yet recruiting
Breathing Exercises of CardioBreath Application on Autonomic and Vascular Function in Hypertension
Active, not recruiting
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Active, not recruiting
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Recruiting
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- High blood pressure1 recruiting
- Peripheral artery disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026